Skip to main content
一致魔芋 logo

一致魔芋 — Investor Relations & Filings

Ticker · 920273 ISIN · CNE100005SP4 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2023-04-12 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920273

About 一致魔芋

http://www.easykonjac.com/

Hubei Yizhi Konjac Biotechnology Co., Ltd. specializes in the research, development, and large-scale production of konjac-based ingredients and consumer products. The company’s core portfolio includes konjac flour, purified glucomannan, and dietary fibers utilized as functional additives, stabilizers, and gelling agents. Beyond food applications, it develops specialized konjac derivatives for the cosmetic and pharmaceutical sectors, including biodegradable materials and moisturizing components. The firm maintains an integrated industrial chain encompassing raw material sourcing and advanced deep-processing technologies. Its products are designed to meet global standards for health-oriented applications, focusing on low-calorie, high-fiber solutions for weight management and digestive wellness. Through continuous biotechnological innovation, the company provides versatile raw materials and finished goods to diverse international markets.

Recent filings

Filing Released Lang Actions
2022年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2022 Annual General Meeting (AGM) of 湖北一致魔芋生物科技股份有限公司. It includes information about the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and votes. The content focuses on the outcomes of shareholder votes on various company reports and proposals, such as the 2022 financial report, profit distribution plan, auditor appointment, and remuneration plans. It does not contain the full annual report or financial statements themselves but rather the official voting results and decisions made at the AGM. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements (DVA)". The document length is over 6,000 characters, indicating it is not a brief notice but a full voting results announcement. Therefore, the correct classification is DVA with high confidence.
2023-04-12 Chinese
投资者关系活动记录表
Regulatory Filings Classification · 95% confidence The document is an investor relations activity record from 湖北一致魔芋生物科技股份有限公司 dated April 10, 2023. It details a specific investor research meeting held on April 7, 2023, including Q&A about the company's financial performance, product sales, market strategy, and operational details. The content is a detailed record of an investor relations event rather than a formal financial report or earnings release. It does not contain full financial statements or comprehensive financial data typical of Annual Reports (10-K), Interim Reports (IR), or Earnings Releases (ER). It is not a presentation (IP) or a proxy solicitation (PSI). The document is a record of an investor relations activity, which is a type of communication with investors but does not fit the other categories. Given the specificity of the categories, the best fit is Regulatory Filings (RNS) as a general regulatory announcement or investor relations disclosure that does not fit other categories. The document length is under 5,000 characters, but it is not merely an announcement of a report publication, so RPA is not appropriate. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2023-04-09 Chinese
投资者关系活动记录表
Call Transcript Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record". It specifically mentions that the company held a "2022年度报告业绩说明会" (2022 Annual Report Earnings Explanation Meeting) on April 7, 2023, conducted online. The content includes a Q&A session with investors discussing the company's 2022 annual performance and outlook, but it is not the annual report itself. The document is a record of the earnings presentation event related to the annual report, i.e., an earnings conference or performance explanation meeting. This fits the definition of a Call Transcript (CT) as it is a full text transcript of a company conference call or earnings call with Q&A. The document length is 5178 characters, which is sufficient for a transcript. It is not the annual report (10-K) itself, nor an announcement of a report (RPA). Therefore, the best classification is Call Transcript (CT).
2023-04-09 Chinese
第三届监事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the fourth meeting of the third Supervisory Board of the company. It details meeting attendance, agenda items, voting results, and decisions related to changes in registered capital, company type, amendments to the articles of association, and use of idle raised funds. There is no financial statement or detailed financial analysis present. The document is a corporate governance announcement about board-level decisions rather than a full management report or financial report. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a shareholder meeting announcement or voting result declaration. The content aligns best with Board/Management Information (MANG) as it concerns board resolutions and governance decisions. The document length is short (1520 characters), and it is not merely announcing a report publication but providing substantive meeting resolution details. Therefore, the classification is MANG with high confidence.
2023-04-05 Chinese
使用闲置募集资金暂时补充流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the temporary use of idle raised funds to supplement working capital by 湖北一致魔芋生物科技股份有限公司. It details the amount of funds raised, their usage, storage, reasons for temporary idleness, and approvals by the board, independent directors, and supervisory board. The document does not contain financial statements or detailed financial performance data but is a regulatory disclosure about the use of raised capital. The length is about 3,039 characters, which is relatively short and consistent with an announcement rather than a full report. This fits the category of Capital/Financing Update (CAP), as it relates to the use of fundraising proceeds and capital management.
2023-04-05 Chinese
关于变更注册资本及修订《公司章程》的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from 湖北一致魔芋生物科技股份有限公司 regarding changes to the company's registered capital and amendments to the Articles of Association. It details the increase in registered capital and share count following a public offering and exercise of an over-allotment option. The document includes references to relevant laws and regulatory approvals but does not contain financial statements or detailed financial performance data. It is a formal announcement about capital changes and corporate governance documents rather than a full financial report or management discussion. The document length is short (1476 characters), and it is clearly an announcement of changes rather than a report itself. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2023-04-05 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.